Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis.

Daware, Snehal; Patki, Manali; Saraswat, Aishwarya; Palekar, Siddhant; Patel, Ketan

Daware, Snehal; Patki, Manali; Saraswat, Aishwarya; Palekar, Siddhant; Patel, Ketan.

Afiliação

Daware S; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Patki M; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Saraswat A; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Palekar S; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Patel K; College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States. Electronic address: patelk2@stjohns.edu.

Int J Pharm ; 626: 122163, 2022 Oct 15.

Article em En | MEDLINE | ID: mdl-36067920

Assuntos

Fasciolíase; Nanopartículas; Criança; Humanos; alfa-Tocoferol; Disponibilidade Biológica; Sistemas de Liberação de Medicamentos; Emulsões; Lipídeos; Tamanho da Partícula; Solubilidade; Solventes; Tensoativos; Comprimidos; Triclabendazol; Triglicerídeos

Palavras-chave

Dose Customization; Pediatric formulations; Self-Nanoemulsifying Preconcentrate; Triclabendazole

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Fasciolíase Limite: Child / Humans Idioma: En Revista: Int J Pharm Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google